Demo Data from EDBT 2026 / reviewers in the wild / expert
Jean-Loup Faulon
dblp:06/4636
· DBLP profile ↗
9ranked-venue papers
3as first author
2since 2021 · last 2026
0000-0003-4274-2953ORCID · reported
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 7 · 2 first-author · 1 since 2021Artificial intelligence and machine learning · 1 · 1 since 2021Systems, architecture and hardware · 1 · 1 first-authorDatabases, data management, data science and information retrieval · 1 · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
8 papers |
Bioinformatics and computational biology · 88% Computational science and engineering · 12% | |
| Computer architecture, parallel and distributed computing, and storage systems
1 paper |
High-performance computing · 100% |
Topics — the 17 heaviest of 18, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › systems biology
metabolic modeling |
1.0 | 1 | 2026 | dAMN: a genome-scale neural-mechanistic hybrid model to predict bacterial growth dynamics · Bioinform. 2026 |
Computational science and engineering › scientific data management
data standards |
0.3 | 1 | 2018 | PartsGenie: an integrated tool for optimizing and sharing synthetic biology parts · Bioinform. 2018 |
Bioinformatics and computational biology › synthetic biology
metabolic pathway design |
0.3 | 1 | 2018 | Selenzyme: enzyme selection tool for pathway design · Bioinform. 2018 |
Bioinformatics and computational biology
synthetic biology |
0.3 | 1 | 2018 | PartsGenie: an integrated tool for optimizing and sharing synthetic biology parts · Bioinform. 2018 |
Bioinformatics and computational biology › protein function prediction
enzyme function prediction |
0.1 | 1 | 2010 | Molecular signatures-based prediction of enzyme promiscuity · Bioinform. 2010 |
Bioinformatics and computational biology › gene expression analysis
molecular signature analysis |
0.1 | 1 | 2010 | Molecular signatures-based prediction of enzyme promiscuity · Bioinform. 2010 |
Bioinformatics and computational biology › drug discovery
drug-target interaction |
0.1 | 1 | 2008 | Genome scale enzyme-metabolite and drug-target interaction predictions using the signature molecular descriptor · Bioinform. 2008 |
Bioinformatics and computational biology › drug discovery
drug-target interaction prediction |
0.1 | 1 | 2008 | Genome scale enzyme-metabolite and drug-target interaction predictions using the signature molecular descriptor · Bioinform. 2008 |
Bioinformatics and computational biology › biological network › network biology › network inference › gene regulatory network inference
boolean network inference |
0.1 | 1 | 2007 | Boolean dynamics of genetic regulatory networks inferred from microarray time series data · Bioinform. 2007 |
Bioinformatics and computational biology
gene expression analysis |
0.1 | 1 | 2007 | Boolean dynamics of genetic regulatory networks inferred from microarray time series data · Bioinform. 2007 |
Bioinformatics and computational biology › biological network › network biology › network inference
gene regulatory network inference |
0.1 | 1 | 2007 | Boolean dynamics of genetic regulatory networks inferred from microarray time series data · Bioinform. 2007 |
Bioinformatics and computational biology › gene expression analysis › time-series gene expression analysis
time-course microarray analysis |
0.1 | 1 | 2007 | Boolean dynamics of genetic regulatory networks inferred from microarray time series data · Bioinform. 2007 |
Bioinformatics and computational biology
protein-protein interaction prediction |
0.1 | 1 | 2005 | Predicting protein-protein interactions using signature products · Bioinform. 2005 |
High-performance computing › scientific computing systems
molecular dynamics simulation |
0.0 | 1 | 1997 | Massively Parallel Simulations of Diffusion in Dense Polymeric Structures · SC 1997 |
High-performance computing
scientific computing systems |
0.0 | 1 | 1997 | Massively Parallel Simulations of Diffusion in Dense Polymeric Structures · SC 1997 |
Bioinformatics and computational biology
protein sequence analysis |
0.0 | 1 | 2005 | Predicting protein-protein interactions using signature products · Bioinform. 2005 |
Computational science and engineering › materials science
materials science simulation |
0.0 | 1 | 1997 | Massively Parallel Simulations of Diffusion in Dense Polymeric Structures · SC 1997 |
Methods — techniques the papers use, named apart from their topics
residual network · 1.0neural network · 1.0genome-scale metabolic model · 1.0sequence similarity · 0.3phylogenetic distance · 0.3multiple alignment · 0.3DNA optimization algorithms · 0.3machine learning · 0.2graph-based molecular signature · 0.1signature molecular descriptor · 0.1tetrahedral meshing · 0.0spatial decomposition · 0.0molecular dynamics · 0.0
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2026 | dAMN: a genome-scale neural-mechanistic hybrid model to predict bacterial growth dynamicsabstractAbstract Summary This study presents dAMN, a genome-scale neural–mechanistic hybrid model that combines neural networks with dynamic flux balance analysis to predict bacterial growth dynamics across diverse nutrient environments. Using a residual network architecture, dAMN predicts reaction fluxes and lag-phase parameters from initial medium composition, then integrates these predictions under stoichiometric constraints derived from genome-scale metabolic models. Trained on Escherichia coli and Pseudomonas putida growth datasets across combinatorial media, dAMN accurately forecasts temporal growth dynamics and generalizes to unseen media conditions, with mean R² ≥ 0.9. The model also reproduces biologically relevant behaviors including substrate depletion, acetate overflow, and diauxic shifts, while explicitly modeling lag phases usually absent from standard dFBA. Availability and implementation The dAMN software, associated models, and datasets are available at https://github.com/brsynth/dAMN-main-release and via Zenodo DOI: 10.5281/zenodo.17908125. Jean-Loup Faulon, Danilo Dursoniah, Paul Ahavi, Antoine Raynal, Enrique Asin-Garcia |
Bioinform. | 1 |
| 2025 | Estimating the Learning Capacity of Bacterial Metabolic Networks
Bastien Mollet, Paul Ahavi, Antoine Cornuéjols, Jean-Loup Faulon, Evelyne Lutton, Alberto Paolo Tonda |
IDA | 4 |
| 2018 | Selenzyme: enzyme selection tool for pathway designabstractSummary: Synthetic biology applies the principles of engineering to biology in order to create biological functionalities not seen before in nature. One of the most exciting applications of synthetic biology is the design of new organisms with the ability to produce valuable chemicals including pharmaceuticals and biomaterials in a greener; sustainable fashion. Selecting the right enzymes to catalyze each reaction step in order to produce a desired target compound is, however, not trivial. Here, we present Selenzyme, a free online enzyme selection tool for metabolic pathway design. The user is guided through several decision steps in order to shortlist the best candidates for a given pathway step. The tool graphically presents key information about enzymes based on existing databases and tools such as: similarity of sequences and of catalyzed reactions; phylogenetic distance between source organism and intended host species; multiple alignment highlighting conserved regions, predicted catalytic site, and active regions and relevant properties such as predicted solubility and transmembrane regions. Selenzyme provides bespoke sequence selection for automated workflows in biofoundries. Availability and implementation: The tool is integrated as part of the pathway design stage into the design-build-test-learn SYNBIOCHEM pipeline. The Selenzyme web server is available at http://selenzyme.synbiochem.co.uk. Supplementary information: Supplementary data are available at Bioinformatics online. Pablo Carbonell, Jerry Wong, Neil Swainston, Eriko Takano, Nicholas J. Turner, Nigel S. Scrutton, Douglas B. Kell, Rainer Breitling, Jean-Loup Faulon |
Bioinform. | 9 |
| 2018 | PartsGenie: an integrated tool for optimizing and sharing synthetic biology partsabstractMotivation: Synthetic biology is typified by developing novel genetic constructs from the assembly of reusable synthetic DNA parts, which contain one or more features such as promoters, ribosome binding sites, coding sequences and terminators. PartsGenie is introduced to facilitate the computational design of such synthetic biology parts, bridging the gap between optimization tools for the design of novel parts, the representation of such parts in community-developed data standards such as Synthetic Biology Open Language, and their sharing in journal-recommended data repositories. Consisting of a drag-and-drop web interface, a number of DNA optimization algorithms, and an interface to the well-used data repository JBEI ICE, PartsGenie facilitates the design, optimization and dissemination of reusable synthetic biology parts through an integrated application. Availability and implementation: PartsGenie is freely available at https://parts.synbiochem.co.uk. Neil Swainston, Mark Dunstan, Adrian J. Jervis, Christopher J. Robinson, Pablo Carbonell, Alan R. Williams, Jean-Loup Faulon, Nigel S. Scrutton, Douglas B. Kell |
Bioinform. | 7 |
| 2010 | Molecular signatures-based prediction of enzyme promiscuityabstractMOTIVATION: Enzyme promiscuity, a property with practical applications in biotechnology and synthetic biology, has been related to the evolvability of enzymes. At the molecular level, several structural mechanisms have been linked to enzyme promiscuity in enzyme families. However, it is at present unclear to what extent these observations can be generalized. Here, we introduce for the first time a method for predicting catalytic and substrate promiscuity using a graph-based representation known as molecular signature. RESULTS: Our method, which has an accuracy of 85% for the non-redundant KEGG database, is also a powerful analytical tool for characterizing structural determinants of protein promiscuity. Namely, we found that signatures with higher contribution to the prediction of promiscuity are uniformly distributed in the protein structure of promiscuous enzymes. In contrast, those signatures that act as promiscuity determinants are significantly depleted around non-promiscuous catalytic sites. In addition, we present the study of the enolase and aminotransferase superfamilies as illustrative examples of characterization of promiscuous enzymes within a superfamily and achievement of enzyme promiscuity by protein reverse engineering. Recognizing the role of enzyme promiscuity in the process of natural evolution of enzymatic function can provide useful hints in the design of directed evolution experiments. We have developed a method with potential applications in the guided discovery and enhancement of latent catalytic capabilities surviving in modern enzymes. AVAILABILITY: http://www.issb.genopole.fr~faulon. Pablo Carbonell, Jean-Loup Faulon |
Bioinform. | 2 |
| 2008 | Genome scale enzyme-metabolite and drug-target interaction predictions using the signature molecular descriptorabstractAbstract Motivation: Identifying protein enzymatic or pharmacological activities are important areas of research in biology and chemistry. Biological and chemical databases are increasingly being populated with linkages between protein sequences and chemical structures. There is now sufficient information to apply machine-learning techniques to predict interactions between chemicals and proteins at a genome scale. Current machine-learning techniques use as input either protein sequences and structures or chemical information. We propose here a method to infer protein–chemical interactions using heterogeneous input consisting of both protein sequence and chemical information. Results: Our method relies on expressing proteins and chemicals with a common cheminformatics representation. We demonstrate our approach by predicting whether proteins can catalyze reactions not present in training sets. We also predict whether a given drug can bind a target, in the absence of prior binding information for that drug and target. Such predictions cannot be made with current machine-learning techniques requiring binding information for individual reactions or individual targets. Availability and Contact: For questions, paper reprints, please contact Jean-Loup Faulon at [email protected]. Additional information on the signature molecular descriptor and codes can be downloaded at: http://www.cs.sandia.gov/~jfaulon/publication-signature.html Supplementary information: Supplementary data are available at Bioinformatics online. Jean-Loup Faulon, Milind Misra, Shawn Martin, Kenneth L. Sale, Rajat Sapra |
Bioinform. | 1 |
| 2007 | Boolean dynamics of genetic regulatory networks inferred from microarray time series dataabstractMOTIVATION: Methods available for the inference of genetic regulatory networks strive to produce a single network, usually by optimizing some quantity to fit the experimental observations. In this article we investigate the possibility that multiple networks can be inferred, all resulting in similar dynamics. This idea is motivated by theoretical work which suggests that biological networks are robust and adaptable to change, and that the overall behavior of a genetic regulatory network might be captured in terms of dynamical basins of attraction. RESULTS: We have developed and implemented a method for inferring genetic regulatory networks for time series microarray data. Our method first clusters and discretizes the gene expression data using k-means and support vector regression. We then enumerate Boolean activation-inhibition networks to match the discretized data. Finally, the dynamics of the Boolean networks are examined. We have tested our method on two immunology microarray datasets: an IL-2-stimulated T cell response dataset and a LPS-stimulated macrophage response dataset. In both cases, we discovered that many networks matched the data, and that most of these networks had similar dynamics. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Shawn Martin, Zhaoduo Zhang, Anthony Martino, Jean-Loup Faulon |
Bioinform. | 4 |
| 2005 | Predicting protein-protein interactions using signature productsabstractMOTIVATION: Proteome-wide prediction of protein-protein interaction is a difficult and important problem in biology. Although there have been recent advances in both experimental and computational methods for predicting protein-protein interactions, we are only beginning to see a confluence of these techniques. In this paper, we describe a very general, high-throughput method for predicting protein-protein interactions. Our method combines a sequence-based description of proteins with experimental information that can be gathered from any type of protein-protein interaction screen. The method uses a novel description of interacting proteins by extending the signature descriptor, which has demonstrated success in predicting peptide/protein binding interactions for individual proteins. This descriptor is extended to protein pairs by taking signature products. The signature product is implemented within a support vector machine classifier as a kernel function. RESULTS: We have applied our method to publicly available yeast, Helicobacter pylori, human and mouse datasets. We used the yeast and H.pylori datasets to verify the predictive ability of our method, achieving from 70 to 80% accuracy rates using 10-fold cross-validation. We used the human and mouse datasets to demonstrate that our method is capable of cross-species prediction. Finally, we reused the yeast dataset to explore the ability of our algorithm to predict domains. CONTACT: [email protected] Shawn Martin, Diana C. Roe, Jean-Loup Faulon |
Bioinform. | 3 |
| 1997 | Massively Parallel Simulations of Diffusion in Dense Polymeric StructuresabstractAn original computational technique to generate close-to-equilibrium dense polymeric structures is proposed. Diffusion of small gases are studied on the equilibrated structures using massively parallel molecular dynamics simulations running on the Intel Teraflops (9216 Pentium Pro processors) and Intel Paragon (1840 processors). Compared to the current state-of-the-art equilibration methods this new technique appears to be faster by some orders of magnitude. The main advantage of the technique is that one can circumvent the bottlenecks in configuration space that inhibit relaxation in molecular dynamics simulations. The technique is based on the fact that tetravalent atoms (such as carbon and silicon) fit in the center of a regular tetrahedron and that regular tetrahedrons can be used to mesh the three-dimensional space. Thus, the problem of polymer equilibration described by continuous equations in molecular dynamics is reduced to a discrete problem where solutions are approximated by simple algorithms. Practical modeling applications include the construction of butyl rubber and ethylene-propylene-dimer-monomer (EPDM) models for oxygen and water diffusion calculations. Butyl and EPDM are used in O-ring systems and serve as sealing joints in many manufactured objects. Diffusion coefficients of small gases have been measured experimentally on both polymeric systems, and in general the diffusion coefficients in EPDM are an order of magnitude larger than in butyl. In order to better understand the diffusion phenomena, 10,000 atoms models were generated and equilibrated for butyl and EPDM. The models were submitted to a massively parallel molecular dynamics simulation to monitor the trajectories of the diffusing species. The massively parallel molecular dynamics code used in this paper achieves parallelism by a spatial-decomposition of the workload which enables it to run large problems in a scalable way where both memory cost and per-timestep execution speed scale linearly with the number of atoms being simulated. It runs efficiently on several parallel platforms, including the Intel Teraflops at Sandia. There are several diffusion modes observed depending if the diffusion is probed at short time scale (anomalous mode) or long time scale (normal mode). Ultimately, the diffusion coefficient that need to be compared with experimental data corresponds to the normal mode. The dynamics trajectories obtained with butyl and EPDM demonstrated that the normal mode was reached for diffusion within one nanosecond of simulation. In agreement with experimental evidences, the oxygen and water diffusion coefficients were found larger for EPDM than butyl. Jean-Loup Faulon, J. David Hobbs, David M. Ford, Robert T. Wilcox |
SC | 1 |